Why Calumet’s latest financing move matters for stockholders

Calumet (CLMT) has just reshaped its capital structure, entering a Tenth Amendment to its main credit agreement to allow new 9.75% senior notes due 2031, a financing step that directly affects equity risk.

The company has now completed a US$157.5 million fixed income offering of these senior unsecured notes, issued at 105% of the US$150 million principal, with attached guarantees. For you as a stockholder, this creates a fresh layer of debt that sits above equity in the capital stack, so it is worth understanding how this interacts with Calumet’s leverage profile and the prospects of its Montana Renewables business.

Despite a 2.4% 1 day share price decline to US$28.04 and softer 7 day trading, Calumet’s 90 day share price return of 40.6% and 1 year total shareholder return of 120.4% suggest momentum has been building around its refinancing progress and Montana Renewables story.

If this kind of re rating has your attention, it could be a good moment to broaden your search and check out 20 top founder-led companies

With shares up 40.6% over 90 days and trading only about 8% below the average analyst price target, the real question is whether Calumet still offers upside or if the market is already pricing in future growth.

Most Popular Narrative: 19.6% Overvalued

Calumet’s most followed narrative pegs fair value at $23.45, which sits below the last close of $28.04, framing an equity story built on renewables and margin uplift.

The MaxSAF 150 project is on track to start up in the first half of 2026, enabling Calumet to produce 120-150 million annual gallons of sustainable aviation fuel (SAF) at relatively low capital costs, capturing premiums of $1-$2/gallon over renewable diesel and tapping into surging mandated and voluntary SAF demand globally; this is likely to drive material step-up in revenues and EBITDA margin expansion once operational.

Curious what earnings path and margin profile need to line up to justify this valuation gap and high implied future multiple? The narrative leans on specific growth rates, profitability shifts, and a rich earnings multiple that looks very different to typical oil and gas names.

Result: Fair Value of $23.45 (OVERVALUED)

However, this hinges on continued regulatory support for renewable fuels and on Calumet managing its substantial debt load without squeezing cash flow or growth options.

Next Steps

With sentiment clearly split between opportunity and risk, now is the time to look through the numbers yourself and pressure test the thesis. To get a balanced view of both the upside and downside flagged in our work, review the 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

If you are weighing what to do next after reviewing Calumet, do not stop here. Fresh ideas can be the difference between staying flat and spotting your next opportunity.

• Target income potential with companies that pay higher yields and assess whether their payouts look durable by reviewing 13 dividend fortresses
• Scan for companies that pair reasonable valuations with business quality and cash generation using the 53 high quality undervalued stocks
• Focus on resilience first and see which names carry lower risk scores relative to peers through the 68 resilient stocks with low risk scores

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.